Combination of automatic HPLC-RIA method for determination of estrone and estradiol in serum

Journal of Clinical Laboratory Analysis

Volumn 13, Issue 6, 1999, Pages 266-272

  Yasui, Toshiyuki ^a   Yamada, Masayo ^a   Kinoshita, Hiromi ^a   Uemura, Hirokazu ^a   Yoneda, Naoto ^a   Irahara, Minoru ^a   Aono, Toshihiro ^a   Sunahara, Satoshi ^b   Mito, Yasuyori ^b   Kurimoto, Fumihiko ^b   Hata, Keishi ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

Author keywords

Estradiol; Estrone; HPLC RIA; Postmenopause

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRONE; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; ARTICLE; AUTOANALYSIS; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE SUBSTITUTION; HUMAN; INTERMETHOD COMPARISON; LIQUID SCINTILLATION COUNTING; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; RADIOIMMUNOASSAY;

EID: 0032720797     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2825(1999)13:6<266::aid-jcla3>3.0.co;2-%23     Document Type: Article

References (23)

1. Robertson RD, Picker RH, Wilson PC, Saunders DM. Assessment of ovulation by ultrasound and plasma estradiol determination. Obstet Gynecol 1979;54:686-690.
2. Okamoto S, Healy DL, Howlett DT, et al. An analysis of plasma estradiol concentrations during clomiphene citrate-human menopausal gonadotropin stimulation in vitro fertilization - embryo transfer program. J Clin Endocrinol Metab 1986;63:736-740.
3. Key TJA, Moore JW. Interference of sex-hormone binding globulin in a no extraction double antibody radioimmunoassay for estradiol. Clin Chem 1988;34:1357-1358.
4. Schloler V, Thode J. Six direct radioimmunoassays of estradiol evaluated. Clin Chem 1988;34:949-52.
5. Vasiliades J, Hilgers T, Gentrup B, Remsburg J. Increased estradiol concentration of unknown origin. Clin Chem 1991;37:2152-2153.
6. Place VA, Powers M, Darley PE, Schenkel L, Good WR. A double-blind comparative study of Estraderm and Premarin in the amelioration of postmenopausal symptoms. Am J Obstet Gynecol 1985;152:1092-1099.
7. Lindsay R, Hart DM, Clark DM. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 1984;63:759-763.
8. Henderson BE, Ross RK, Paganini-Hill A, Mack TM. Estrogen use and cardiovascular disease. Am J Obstet Gynecol 1986;154:1181-1186.
9. Chetkowski RJ, Meldrm DR, Steingold KA, et al. Biological effects of transdermal estradiol. N Engl J Med 1986;314:1615-1620.
10. Barbieri RL. Hormone treatment of endometriosis: the estrogen threshold hypothesis. Am J Obstet Gynecol 1992;166:740-745.
11. Mikhail G, Wu CH, Ferin M, Vande Wiele RL. Radioimmunoassay of plasma estrone and estradiol. Steroids 1970;15:333-352.
12. Wu CH, Lundy LE. Radioimmunoassay of plasma estrogens. Steroids 1971;18:91-111.
13. Stoks PG, Benraad TJ. Rapid separation of plasma steroids by reversed-phase high-performance liquid chromatography with timed collection of fractions. J Chromatogr 1983;208:408-412.
14. Imaizumi N, Morimoto S, Kigoshi T, Uchida K, Hosojima H, Yamamoto I. Application of reversed-phase high-performance liquid chromatography for radioimmunoassay of plasma 18-hydroxycorticosterone. J Chromatogr 1984;308:295-300.
15. Schoneshofer M, Fenner A, Dulce HJ. Assessment of eleven adrenal steroids from a single serum sample by combination of automatic high-performance liquid chromatography and radioimmunoassay (HPLC-RIA). J Steroid Biochem 1981;14:377-386.
16. Ueshiba H, Segawa M, Hayashi T, Miyachi Y, Irie M. Serum profiles of steroid hormones in patients with Cushing's syndrome determined by a new HPLC/RIA method. Clin Chem 1991;37:1329-1333.
17. Meldrum DR, Davidson BJ, Tataryn IV, Judd HL. Changes in circulating steroids with aging in postmenopausal women. Obstet Gynecol 1981;57:624-628.
18. Judd HL, Judd GE, Lucas WE, Yen SSC. Endocrine function of the postmenopausal ovary; concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab 1974;39:1020-1024.
19. Judd HL, Shamonski IM, Frumar AM, Lagasse LD. Origin of serum estradiol in postmenopausal women. Obstet Gynecol 1982; 59:680-686.
20. Weinstein L, Bewtra C, Gallagher JC. Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patients. Am J Obstet Gynecol 1990;162:1534-1542.
21. Prince RL, Smith M, Dick IM, et al. Prevention of postmenopausal osteoporosis. N Engl J Med 1991;325:1189-1195.
22. Yoneda N, Uemura H, Yasui T, Azuma K, Irahara M, Aono T. Assessment of the efficacy and compliance of the protocol with every other day administration of estrogen and progestin in hormone replacement therapy for women with menopausal symptoms. J Jpn Menopause Soc 1996;4:65-71.
23. Ettinger B, Pressman A, Sklarin P, Bauer DC, Cauley JA, Commings SR. Associations between low levels of serum estradiol, bone density, and fractures among elderly women: the study of osteoporotic fractures. J Clin Endocrinol Metab 1998;83:2239-2243.